Understand Aspirin Allergy (ASA Allergy), also known as Salicylate Allergy, and sometimes related to NSAID allergy. This resource provides information on diagnosis, clinical documentation, and medical coding for Aspirin Allergy in healthcare settings. Learn about symptoms, testing, and management of ASA allergy for accurate medical records and appropriate billing.
Also known as
Allergy, unspecified drug
Adverse reaction to aspirin or other salicylates.
Allergy status to drugs, medicaments and biological substances
Personal history of allergy to aspirin or salicylates.
Other adverse effects, not elsewhere classified
Adverse effect of aspirin, such as gastrointestinal bleeding, not due to allergy.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the aspirin allergy confirmed?
When to use each related code
| Description |
|---|
| Allergic reaction to aspirin. |
| Allergic reaction to nonsteroidal anti-inflammatory drugs (NSAIDs). |
| Intolerance to NSAIDs, causing GI upset. |
Coding Aspirin Allergy without specifying manifestation (rash, anaphylaxis) may lead to under-coding and inaccurate severity reflection.
Documenting 'NSAID allergy' may be miscoded as a true allergy instead of intolerance or sensitivity, impacting medication choices.
Lack of documented allergy validation (e.g., allergy testing, reaction details) poses a risk for inaccurate coding and potential adverse events.
Q: How can I differentiate between true aspirin allergy, aspirin exacerbated respiratory disease (AERD), and other NSAID hypersensitivity reactions in clinical practice?
A: Differentiating between these conditions requires a thorough clinical history and potentially diagnostic testing. True aspirin allergy, also known as ASA allergy or salicylate allergy, is an IgE-mediated reaction that can manifest as urticaria, angioedema, or even anaphylaxis shortly after aspirin ingestion. Aspirin exacerbated respiratory disease (AERD), while triggered by aspirin and other NSAIDs, is not IgE-mediated and typically presents with worsening asthma, nasal congestion, and nasal polyps. Other NSAID hypersensitivity reactions can involve various mechanisms and symptoms. Skin prick testing and oral aspirin challenge testing, performed in a controlled environment, can help confirm the diagnosis. Explore how allergists utilize these tests for precise diagnosis and personalized management of aspirin sensitivity. Consider implementing standardized diagnostic pathways in your practice to improve patient outcomes. Learn more about the different types of NSAID hypersensitivity reactions and their respective management strategies.
Q: What are the best evidence-based management strategies for patients with a confirmed aspirin allergy, including both pharmacological and non-pharmacological approaches?
A: Management of confirmed aspirin allergy centers around strict avoidance of aspirin and, in many cases, other NSAIDs due to potential cross-reactivity. This includes not only over-the-counter pain relievers but also medications containing salicylates, found in some foods and cosmetics. Patient education is paramount, emphasizing the importance of reading medication labels and informing all healthcare providers about the allergy. For pain management, alternative analgesics such as acetaminophen or opioids may be considered, though careful assessment of risks and benefits is crucial. In cases of AERD, leukotriene modifiers and biologics targeting specific inflammatory pathways can be beneficial. Learn more about desensitization protocols for patients with AERD who require aspirin for cardiovascular or other medical reasons. Consider implementing a shared decision-making approach with patients to tailor management strategies to individual needs and preferences.
Patient presents with a history of aspirin allergy, also known as ASA allergy or salicylate allergy. The onset and nature of the allergic reaction were explored, including symptoms such as urticaria, angioedema, bronchospasm, or anaphylaxis. Severity of past reactions was documented, ranging from mild cutaneous manifestations to life-threatening respiratory compromise. Differential diagnoses considered included other drug hypersensitivity reactions and pseudoallergic reactions to NSAIDs. Patient education regarding aspirin avoidance, including over-the-counter medications containing salicylates, was provided. Emphasis was placed on reading medication labels and informing all healthcare providers of this allergy. A medical alert bracelet was recommended. The patient was advised on appropriate alternative analgesics and antipyretics. Anaphylaxis management protocols, including the use of epinephrine auto-injectors, were reviewed if indicated by reaction history. This diagnosis of aspirin allergy necessitates careful medication reconciliation and documentation in the electronic health record for patient safety and to facilitate accurate medical billing and coding. The ICD-10 code T78.40XA (allergy, unspecified, initial encounter) or more specific codes such as T78.0XXA (anaphylactic shock due to adverse food reaction, initial encounter) if applicable, may be utilized for medical coding purposes. Future treatment plans will incorporate this allergy information to prevent adverse drug reactions.